Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
The financial sector kicks off 2026 with its sharpest early-year drop in a decade. Analysts say high-ROE, low-P/E scr...
SoFi Technologies could be on the verge of a significant rerating as revenue and members keep growing. This guide div...
When digital assets are seized, custody rules matter as much as the seizure itself. This article breaks down what hap...
Major retailers report this week to reveal whether consumer demand is stabilizing and margins are restoring. Here’s w...
When high-growth stocks stumble after earnings, it sparks questions for investors. This article digs into why On Hold...
Vitalik Buterin reveals an ambitious plan to build 'sanctuary technologies' within Ethereum, aiming to shield people ...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Cardano is accelerating governance upgrades to win enterprise adoption in a stricter regulatory era. The network rati...
The Midwest is driving the national housing surge, with absorption outpacing supply. Detroit, Chicago and Cleveland s...
The Mortgage Bankers Association and allied groups urge the VA to simplify loss-mitigation rules for VA-backed loans,...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...